| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.65 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |